Dr. Denis-Claude Roy from the University of Montreal, Canada is our leading academic partner for the development of our blood cancer products and has collaborated with Kiadis Pharma for many years. Dr. Roy significantly contributed to the developmen... read more 

Dr. Velardi from University of Perugia, Italy, is one of the foremost authorities on the development of haploidentical transplantation procedures. During the past two years, Dr. Velardi has evaluated the ability of ATIR™ and subsequently initiated... read more 

In Germany Kiadis Pharma collaborates with Dr. Stephan Mielke and Professor Dr. Hermann Einsele from the Allogeneic Stem Cell Transplant Center at the Julius-Maximilians University of Würzburg, Germany. Principal investigator of this collaboration w... read more 

In the United States Kiadis Pharma collaborates with the NIH on its lead program ATIR™:
The NIH team of Dr. Barrett, head of the transplantation unit, aims to significantly improve the outcome of hematopoietic stem cell transplantation (HSCT) proced... read more